通过调节细胞增殖和免疫透,CLK1是NSCLC的潜在瘤抑制剂
Rui Ma1,2,3, Xiaoyan Zhang1,2, Yunlong Wang3
1College of Life Science and Technology, Huazhong Agricultural University, Wuhan, China.
Frontiers in cell and developmental biology
|February 25, 2026
概括
在非小细胞肺癌 (NSCLC) 中,CLK1充当瘤抑制剂,抑制癌症生长并增强免疫反应. 高CLK1表达与更好的生存率和化疗敏感性相关,表明其作为预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 由于高发病率,死亡率,耐药性和不良预后,给全球健康带来了重大挑战.
- 在NSCLC中CLK1的作用,特别是关于瘤免疫透,尽管已知其参与其他疾病,但仍然在很大程度上未被探索.
- 在各种癌症中CLK1的功能及其对化疗耐药性的潜在影响强调了在NSCLC进一步研究的必要性.
研究的目的:
- 研究CLK1在NSCLC中的表达和预后意义.
- 阐明CLK1在NSCLC增殖和抗瘤免疫中的功能作用.
- 探索CLK1作为药物敏感性的预测生物标志物和NSCLC治疗点的潜力.
主要方法:
- 使用像GEPIA和UALCAN这样的平台,对各种癌症和肺腺癌 (LUAD) 的CLK1表达和预后进行生物信息分析.
- 功能性丰富分析 (GSEA,KEGG,GO) 以确定与CLK1相关的途径及其与免疫透的相关性.
- 使用NSCLC患者样本和细胞系 (A549,H1299) 的药物敏感性查和实验验证实,以评估CLK1对增殖和化疗反应的影响.
主要成果:
- 与其在其他癌症中的致癌作用相反,CLK1在NSCLC中起着瘤抑制作用.
- 高CLK1表达与改善患者存活率,抑制细胞循环和新陈代谢以及增强抗瘤免疫力有关,包括CD4+ T细胞透.
- 在NSCLC组织中观察到CLK1下调,其过度表达抑制了癌细胞增殖in vitro,与增加的瘤突变负担和化疗敏感性相关.
结论:
- 在NSCLC中,CLK1充当瘤抑制基因,抑制增殖并促进免疫透.
- CLK1表达作为一个积极的预后生物标志物,与增强的抗瘤免疫力和对化疗的敏感性相关.
- CLK1代表了旨在改善NSCLC患者治疗结果的组合疗法的潜在治疗标.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K


